1538 / 1851
GOG-0249
•
Phase III study of pelvic RT vs. vaginal BT + 3# carbo-Taxol
chemotherapy
•
High-intermediate risk factors (GOG-99) - G2 or 3, LVSI,
deep myometrial invasion:
–
Stage I, age ≥ 70, 1 risk factor
–
Stage I, age ≥ 50, 2 risk factors
–
Stage I, age ≥ 18, 3 risk factors
–
Stage II disease with or without risk factors
•
Target accrual = 562